Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This multimodal intervention protocol, spearheaded by Eunice Dube, is designed to address the high burden of Hepatitis B (HBV) and Human Papillomavirus (HPV) related cancers in Zimbabwe. The approach combines the administration of the Gardasil 9 vaccine (targeting nine HPV types) and a standard Hepatitis B virus vaccine with Cognitive Behavioral Therapy (CBT). The program targets women of childbearing age and young adults, aiming to provide primary prevention against cervical and liver cancers while simultaneously addressing mental health concerns like depression and anxiety through behavioral intervention. This multifaceted strategy seeks to improve vaccine uptake and overall health outcomes in a resource-limited setting by integrating preventive immunization with psychological support.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Gardasil 9 + hepatitis B vaccine + cognitive behavioral therapy.